Company intelligence / Profile preview

Anova Biomedical

New York, United Stateslifescienceventures.cornell.edu ↗

Ownership: Private
Development stage: Preclinical

Overview

Anova Biomedical is developing the first fully synthetic and bioresorbable vascular grafts. The company has received an NSF SBIR Phase I award to support research into 3D printing of personalized vascular grafts using novel elastomeric resins. Clinical results are not yet available as the technology appears to be in preclinical or early-stage development.

Therapeutic areas: Cardiovascular
Modalities: DeviceBioresorbable vascular grafts (Medical device/biomaterial)
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Anova Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anova Biomedical.

Explore the full profile